AVAH · Aveanna Healthcare Holdings Inc
$9.45
+2.28% last session
End-of-day data · updated 2026-07-28
Market cap
$2B
Enterprise value
$3B
Trailing P/E
8.0
Forward P/E
12.5
Dividend yield
—
Beta
1.89
Avg volume
2M
Employees
4K
2D change
—
5D change
6.50%
10D change
-0.21%
30D change
11.66%
60D change
34.87%
MTD change
9.14%
YTD change
18.36%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AVAH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-14
Latest call per bank · past 12 months
Barclays
Overweight$9.50
+0.5% vs priceRBC Capital
Outperform$10.00
+5.8% vs priceUBS
Neutral$10.00
+5.8% vs priceJefferies
Buy$12.50
+32.3% vs priceJP Morgan
Neutral$10.00
+5.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-14 | Truist Securities | Maintains | Hold | $9.00 → $11.00 |
| 2026-07-09 | Barclays | Maintains | Overweight | $9.00 → $9.50 |
| 2026-06-03 | RBC Capital | Upgrade | Sector Perform → Outperform | $10.00 |
| 2026-05-20 | Truist Securities | Maintains | Hold | $8.00 → $9.00 |
| 2026-05-18 | Barclays | Maintains | Overweight | $9.50 → $9.00 |
| 2026-05-15 | Stephens & Co. | Upgrade | Equal-Weight → Overweight | $10.00 → $11.00 |
| 2026-05-15 | RBC Capital | Maintains | Sector Perform | $9.00 → $10.00 |
| 2026-04-13 | Truist Securities | Maintains | Hold | $9.00 → $8.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 19.7% above the 50-day MA ($8.26).
- Price vs 200-day MA: Trading 22.4% above the 200-day MA ($8.08).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.07) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($10.27).
AVAH Price Chart
Loading chart for AVAH…
Fundamentals
About Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.